Global Statin Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Statin Market Research Report 2024
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients.
According to Mr Accuracy reports’s new survey, global Statin market is projected to reach US$ 16430 million in 2034, increasing from US$ 14430 million in 2024, with the CAGR of 1.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Statin market research.
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe followed by North America has witnessed highest elevated total cholesterol level worldwide. There has been a significant rise in patients with obesity, cardiovascular diseases and diabetes which in turn is expected to drive the demand for statins worldwide. In North America, over 70% American adults are suffering from LDL cholesterol. As such, demand for effective treatment of LDL cholesterol has led to increased demand of statins globally. Furthermore, increase in healthcare expenditure in emerging regions along with technological advancement, modern healthcare amenities, and various cholesterol related healthcare campaign is expected to boost overall demand for stains worldwide.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Statin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma
Segment by Type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Statin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Statin market is projected to reach US$ 16430 million in 2034, increasing from US$ 14430 million in 2024, with the CAGR of 1.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Statin market research.
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe followed by North America has witnessed highest elevated total cholesterol level worldwide. There has been a significant rise in patients with obesity, cardiovascular diseases and diabetes which in turn is expected to drive the demand for statins worldwide. In North America, over 70% American adults are suffering from LDL cholesterol. As such, demand for effective treatment of LDL cholesterol has led to increased demand of statins globally. Furthermore, increase in healthcare expenditure in emerging regions along with technological advancement, modern healthcare amenities, and various cholesterol related healthcare campaign is expected to boost overall demand for stains worldwide.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Statin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma
Segment by Type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Segment by Application
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Statin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source